BNA™ Analysis system is cleared by the FDA for marketing in the US .
ElMindA’s BNA™ technology is based on non-invasive recordings of multi-channel ERPs, a direct measure of neural activity, and a comprehensive and advanced analysis of these recordings to form Brain Network Activation patterns (BNAs) in order to map neural pathways that …Read More
BNA™ serves as a valuable tool in CNS drug development, providing the means to quantify drug-induced neuro-physiological changes in brain network activity. The BNA™ technology has been adopted by major pharmaceutical companies for drug development.Read More
The BNA™ technology can potentially serve as an objective tool for patient evaluation and management during the recovery from a concussion, by providing objective and direct metrics of the brain’s neuro-physiological changes. The technology has attracted top key opinion leaders in concussion.Read More